Key facts
- It has raised $140K; the latest was Seed Round ($140K) in Jun 2025.
- Notable investors include Right Side Capital Management, Forum Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for NeuralCure AI
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuralCure AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuralCure AI
Operator of an AI-driven healthcare technology company intended to serve research organizations, healthcare facilities, medical clinics and imaging service providers. The company uses AI-powered medical imaging diagnostics, rapid treatment protocol simulations and perfect match protocol modules to simulate disease progression and predict optimal repair protocols in real time, enabling clients to accelerate breakthroughs, enhance patient outcomes and optimize operational efficiency.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2025
- Website
- getstarted.neuralcure.ai/
- Ownership
- Privately Held (backing)
NeuralCure AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuralCure AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuralCure AI in its N-PORT filings yet. We sweep new filings monthly.